Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
13F holders, Q4 2023
Institutional positions in Aspire Biopharma Holdings, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −3 vs. Q3 2023
- Shares held
- 8.97M
- −424.4K (−4.5%) vs. Q3 2023
- Total value
- $590.3K
- +$95.6K (+19.3%) vs. Q3 2023
- New holders
- 1
- 1 more added
- Sold out
- 4
- 2 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBPW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $145.4K |
| Q1 2026 | 31 | $121.7K |
| Q4 2025 | 31 | $142.5K |
| Q3 2025 | 31 | $246.3K |
| Q2 2025 | 31 | $395.1K |
| Q1 2025 | 29 | $639.8K |
| Q4 2024 | 28 | $378.3K |
| Q3 2024 | 32 | $343.1K |
| Q2 2024 | 35 | $289.3K |
| Q1 2024 | 36 | $299.9K |
| Q4 2023 | 37 | $590.3K |
| Q3 2023 | 40 | $494.7K |
| Q2 2023 | 41 | $490.5K |
| Q1 2023 | 36 | $399.0K |
| Q4 2022 | 37 | $627.8K |
| Q3 2022 | 37 | $1.28M |
| Q2 2022 | 37 | $1.38M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cohanzick Management, LLC | 166,667 | $0 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 10 | $1 | 0.00% | 00.0% | Unchanged |
| Athos Capital Ltd | 21,383 | $233 | 0.36% | 00.0% | Unchanged |
| Bulldog Investors, LLP | 12,500 | $634 | 0.00% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 12,500 | $750 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 23,803 | $1.43K | 0.00% | −2,547−9.7% | Reduced |
| Meteora Capital, LLC | 25,000 | $1.50K | 0.00% | 00.0% | Unchanged |
| EHP Funds Inc. | 25,000 | $1.50K | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 25,000 | $1.50K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 26,190 | $1.57K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 25,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 46,560 | $2.79K | 0.00% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 50,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Atalaya Capital Management LP | 50,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 53,099 | $3.19K | 0.00% | −1,400−2.6% | Reduced |
| Caas Capital Management LP | 75,000 | $4.50K | 0.00% | 00.0% | Unchanged |
| Kim, LLC | 100,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Flow State Investments, L.P. | 100,000 | $6.00K | 0.00% | +3,832+4.0% | Added |
| JPMorgan Chase & Co | – | $6.00K | 0.00% | – | New |
| Whitebox Advisors LLC | 125,000 | $7.50K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 125,000 | $7.50K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 138,536 | $8.31K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 150,000 | $9.07K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 175,000 | $10.5K | 0.00% | 00.0% | Unchanged |
| Spartan Fund Management Inc. | 187,080 | $11.2K | 0.01% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 199,999 | $12.0K | 0.00% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 300,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 350,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 401,544 | $24.1K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 432,757 | $26.0K | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 500,000 | $32.5K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 647,633 | $38.9K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $45.0K | 0.00% | – | – |
| Linden Advisors LP | 899,999 | $58.5K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $63.0K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 983,603 | $63.9K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 1,461,965 | $87.7K | 0.01% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 0 | $0 | 0.00% | −163,800−100.0% | Sold out |
| Sage Rock Capital Management LP | 0 | $0 | 0.00% | −160,076−100.0% | Sold out |
| HGC Investment Management Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −453−100.0% | Sold out |